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Abstract: Newcastle disease virus (NDV) infections are well known to harbour quasispecies, due to
the error-prone nature of the RNA polymerase. Quasispecies variants in the fusion cleavage site of
the virus are known to significantly change its virulence. However, little is known about the genomic
patterns of diversity and selection in NDV viral swarms. We analyse deep sequencing data from
in vitro and in vivo NDV infections to uncover the genomic patterns of diversity and the signatures
of selection within NDV swarms. Variants in viruses from in vitro samples are mostly localised in
non-coding regions and 3′ and 5′ untranslated regions (3′UTRs or 5′UTRs), while in vivo samples
contain an order of magnitude more variants. We find different patterns of genomic divergence and
diversity among NDV genotypes, as well as differences in the genomic distribution of intra-host
variants among in vitro and in vivo infections of the same strain. The frequency spectrum shows
clear signatures of intra-host purifying selection in vivo on the matrix protein (M) coding gene and
positive or diversifying selection on nucleocapsid (NP) and haemagglutinin-neuraminidase (HN).
The comparison between within-host polymorphisms and phylogenetic divergence reveals complex
patterns of selective pressure on the NDV genome at between- and within-host level. The M sequence
is strongly constrained both between and within hosts, fusion protein (F) coding gene is under
intra-host positive selection, and NP and HN show contrasting patterns: HN RNA sequence is
positively selected between hosts while its protein sequence is positively selected within hosts, and NP
is under intra-host positive selection at the RNA level and negative selection at the protein level.
Keywords: Newcastle disease virus; deep sequencing; intra-host variability; quasispecies; genetic
diversity; genetic variability; Tajima’s D; McDonald–Kreitman test
1. Introduction
RNA viruses often have high mutation rates due to the error-prone nature of RNA polymerases [1,2].
Inside a host, viral RNA polymerases induce roughly 10−4 mutations per nucleotide copied due to low
fidelity, and this may result in the formation of a viral swarm, i.e., a pool of similar genotypes differing
only by a handful of mutations [1,2]. This is a distinctive pattern of intra-host genetic variability
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in organisms with high mutation rates. In viral infections, this is frequently related to quasispecies
dynamics, with complex interactions between the viruses in the swarm [1,2]. Viral quasispecies is
defined as an assortment of closely related viral genomes subjected to a continuous process of genetic
variation, competition between the generated variants, and selection of the fittest distributions in a
specified environment [3].
Newcastle disease virus (NDV) is an economically significant poultry pathogen causing Newcastle
disease, which is widespread in many countries worldwide, and also known to infect over 250 bird
species [4]. NDV is also well known for its oncolytic and immunostimulatory properties in human
cancer cells. Extensive research is ongoing to develop NDV-based oncovirotherapeutics as a potential
cure for cancer [5,6]. NDV is an enveloped virus, which contains an approximately 15 kb long
non-segmented, single-stranded, negative-sense RNA genome. NDV belongs to the Orthoavulavirus
genus of the Avulavirinae subfamily in the Paramyxoviridae family of the Mononegavirales order [7].
The NDV genome encodes six major structural proteins: nucleocapsid protein (NP), phosphoprotein
(P), matrix protein (M), fusion protein (F), haemagglutinin-neuraminidase protein (HN), and large
RNA-dependent RNA polymerase (L) in the order of 3′-NP-P-M-F-HN-L-5′ [8,9].
NDV virions are enveloped within a lipid membrane derived from the host cell plasma membrane.
Two transmembrane glycoproteins are expressed on the surface of the viral envelope; the HN and F
proteins. A non-glycosylated membrane M protein lies underneath the envelope. The ribonucleotide
protein (RNP) replication complex comprises a viral nucleocapsid that includes the NP, P and L proteins
encapsidating the (−) ssRNA genome. Each gene in the NDV genome is tagged by conserved gene
start (GS), and gene end (GE) sequences and two genes are split by a conserved intergenic sequence
(IGS), which regulates mRNA transcription [10]. IGS lengths vary in between two genes from 1 to
47 nucleotides: IGS in NP–P, P–M, and M–F gene junctions contain 1 nucleotide whereas F–HN and
HN–L gene junctions contain 31 and 47 nucleotides, respectively [10].
NDV pathotyping is based on clinical characterization in specific pathogen-free (SPF) chicken
embryos or birds and mainly classified in three pathotypes: (i) velogenic (highly pathogenic and
highly virulent causing viscerotropic and/or neurotropic disease with severe mortality), (ii) mesogenic
(moderately pathogenic with moderate virulence causing chronic respiratory disease with as high as
50% mortality and reduced egg production), (iii) lentogenic (low virulence causing respiratory disease
with fewer mortalities, and reduced egg production), and (iv) avirulent (asymptomatic virus causing
no disease in infected chickens) [11]. The number of basic amino acids present in the F protein cleavage
site (FPCS) of NDV is a main determining factor of the pathogenicity [8,9]. Lentogenic strains of NDV
have fewer basic amino acids in its FPCS (112-G/E-K/R-Q-G/E-R↓L-117), which can only be cleaved
by trypsin and trypsin-like proteases found in respiratory and gastrointestinal tracts. The FPCS of
lentogenic strains presents a limitation of monocyclic replication in the restricted location. By contrast,
velogenic/mesogenic strains of NDV have polybasic amino acids in its FPCS (112R/K-R-Q-K/R-R↓F-117),
which can be cleaved by furin-like proteases found in all cells, which results in the polycyclic virus
replication and establishment of systemic infection [12]. In documented outbreaks in Ireland, 1990 [13]
and Australia from 1998 to 2000 [14], low virulent NDV strains gained high virulence through confirmed
mutations. This suggested that as small as a two-nucleotides change may result in a change in the
virulence of NDV. Despite having well-recognised antigenic and genetically diverse nature, NDV has
only one serotype [15].
There are two phylogenetic classification systems used worldwide based on the NDV genome
length and partial or full coding sequence of F gene with minimal consensus: the first one is suggested
by Aldous, where he groups NDV into 6 lineages and 13 sublineages with a later addition of 3 more
sublineages [16]. The second classification system divides NDV into two clades: class I and class II.
Class I clade is further divided into 9 genotypes (1–9). Class II clade is divided into 11 genotypes
(I–XI) [17,18]. However, Dimitrova et al. published an updated and cohesive phylogenetic classification
system for NDV, where the consensus system maintained class I and class II classification with standing
genotypes, added three genotypes in class II and reduced the number of sub-genotypes [19].
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NDV is thought to have a relatively low mutation rate among RNA viruses [20]. However,
recent phylogenetic estimates of the substitution rate are large enough to suggest the presence of
within-host diversity [19,21]. In fact, NDV infections are well known to harbour quasispecies, and a
significant amount of research has focused on the different profiles of virulence determined by mutations
in the F protein cleavage site. These mutations are sometimes polymorphic within NDV quasispecies and
can transform avirulent lineages into highly pathogenic ones [22,23] representing, therefore, a potential
risk for animal health.
Despite this, very little is known or has been done about the characterisation of the genomic
patterns of diversity and selection in NDV viral swarms. Mutational biases in NDV quasispecies have
been recently described [24], but without any discussion of the patterns of variants across different
strains, genes or hosts.
In this paper, we leverage several datasets of short-read data from RNA-sequencing of NDV
infections, containing both cellular and viral transcriptomes as well as viral RNA genomes, to extract
information about the genomic patterns of diversity and the signatures of selection within NDV
swarms. The RNA-seq data include samples from trachea, lung and spleen of embryos from Fayoumi
and Leghorn breeds experimentally infected with LaSota, as well as chicken embryo fibroblast (CEF)
cells infected in vitro by LaSota and Herts/33 (12 hpi). NDV strain LaSota is a lentogenic/vaccine
strain that belongs to genotype II, and Hers/33 is a highly pathogenic/velogenic strain belonging to
genotype IV. Here, we compared both diversity patterns and selection pressure at the amino acid level
(i.e., dN/dS) across different genes, strains (LaSota vs. Herts/33), experimental conditions (in vivo vs.
in vitro) and hosts (resistant Fayoumi vs. susceptible Leghorn chickens).
2. Materials and Methods
2.1. Cell Culture
For in vitro studies, CEF cells were harvested from 10-day old specific pathogen-free (SPF) chicken
embryos and maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
foetal bovine serum (FBS) at 37◦C with 5% CO2. Cultured CEF cells after attaining 80% confluence
were infected with LaSota or Herts/33 at a MOI of 1 and incubated at 37◦C with 5% CO2 for 1 h.
Later, infected CEF cells were cultured in 2% FBS containing DMEM and cells were harvested before
12-h post infection. LaSota is a lentogenic widely used vaccine strain belonging to type II genotype,
whereas Herts/33 is a highly virulent NDV strain belonging to type IV genotype. LaSota and Herts/33
NDV strains were propagated in 9- to 11-day-old SPF chicken embryos. Allantoic fluid from LaSota
infected SPF embryos was harvested 96 h after inoculation whereas for Herts/33 allantoic fluid was
harvested after embryo death.
2.2. RNA Extraction and Sequencing
Total RNA was extracted from LaSota- or Herts/33-infected CEF cells 12 h post-infection using
TRIzol (Invitrogen, San Diego, CA, USA) according to the manufacturer’s instructions. RNA purification
and degradation were determined by using 1% agarose gel electrophoresis and quantified using Qubit®
RNA Assay Kit and Qubit® 2.0 Fluorometer (Life Technologies, San Diego, CA, USA). RNA integrity
was determined using an RNA Nano 6000 Assay Kit and Bioanalyzer 2100 system (Agilent Technologies,
Santa Clara, CA, USA). Transcriptome libraries were constructed by using protocols provided by
Beijing Novogene Biotechnology Co., Ltd., Beijing, China. Three µg RNA was used per sample,
where ribosomal RNA was removed using an Epicentre Ribo-zeroTM rRNA Removal kit (Epicentre,
Madison, WI, USA). Then, sequencing libraries were consequently synthesized using rRNA-depleted
RNA with a NEBNext® UltraTM Directional RNA Library Prep kit for Illumina® (NEB, Ipswich, MA,
USA), according to the manufacturer’s instructions. Paired-end sequencing was performed on an
Illumina HiSeq2500 sequencer (Illumina, San Diego, CA, USA) with a read length of 125 nucleotides.
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2.3. In Vivo Studies
For in vivo studies, 21-day-old Fayoumi and Leghorn chickens were infected with 200 µL of
107 embryos infectious dose (EID) of 50% of LaSota through intranasal and ocular routes, where 50 µL
of virus was inoculated in each eye and nostrils for the infection in each chicken line. LaSota strain
used in the in vivo studies was propagated in 10-day old SPF chicken embryo and allantoic fluid was
harvested after 2 days. The entire trachea was harvested from infected chicken 2-days post-infection.
Each of the harvested trachea was stored for short term in RNAlater solution (Thermo Fisher Scientific,
Waltham, MA, USA). The sheet of epithelial cells from each trachea was harvested using forceps and
stored at −80 ◦C. The RNA was isolated from epithelial cells using an RNAqueous kit (Thermo Fisher
Scientific, Waltham) and then RNA samples were treated with DNase using a DNA-free kit (Thermo
Fisher Scientific, Waltham). The quality of RNA samples was assessed using he Fragment Analyzer
(Advanced Analytical Technologies, Ankeny, IA, USA). The cDNA library was prepared using the
TruSeq RNA sample preparation guide (v2; Illumina, San Diego, CA, USA) utilising 500 ng RNA
samples and samples were sequenced using the HiSeq2500 platform (Illumina) for 100 bp, single-end
reads (DNA Facility, Iowa State University, Ames, IA, USA).
2.4. Bioinformatic Analyses
Datasets from both in vitro and in vivo experiments are summarized in Table S1 and number of
reads are summarized in Table 1.
Table 1. Number of reads of different samples generated from two different deep sequencing projects.
Samples Total Number of Sequenced High
Quality Nucleotides
Number of Bases with























Short-read RNA sequencing data were obtained from the authors of the original publications [25–28].
We aligned the reads to the most appropriate viral reference. For the data from in vitro experiments
in [25], we used LaSota sequence with GenBank accession JF950510 and Herts/33 sequence AY741404 as
reference sequences. For the in vivo data from [26–28] we aligned reads to LaSota sequence AF077761.
All sequences have the same annotation, that is, the same functional annotated regions located at the
same aligned positions.
Reads were aligned to the combined transcriptome of NDV and Gallus gallus (genome build
GRCg6a, gene build 2018-03) with the GEM aligner [29], using the RNA-pipeline of gemtools with
default parameters. Reads were filtered for mapping and base quality >30 using SAMtools [30].
Variants were called using SiNPle v1.0 [31] with default parameters, retaining only single nucleotide
polymorphisms (SNPs) that were called with a posterior probability >95%.
After SNP calling, the variants were filtered to avoid the presence of sequencing error. The filters
used were a minimum number of reads per position and a minimum frequency to consider a variant.
Following empirical and theoretical justifications for such filters [32–35], we used a minimum number
of 100 reads and a minimum frequency (min_freq) of 0.02. The reasons are the following: (i) we need a
uniform threshold in frequency f req across the whole genome, in order to provide a fair comparison
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between different genomic regions; the only alternative are complex corrections for depth [35] that
require a knowledge of the expected underlying structure of the swarm; (ii) read depth implies an
implicit threshold in frequency, that should be always lower than the explicit one for this comparison to
be fair; (iii) assuming that 2 reads are enough for calling, this implies an implicit threshold of 2/depth,
hence depth ≥ depth = 2/ f req is the appropriate threshold in depth. In summary, these threshold
values highly reduce (or eliminate) the presence of sequencing errors, enable comparisons between
genomic regions, and only affect a range of frequencies (the lowest).
All analyses of genetic variability were implemented in R (code available from the authors upon
request). Sequences of genotype II and IV used to compute divergence within genotypes are shown in
Supplementary Figure S1; their tree was reconstructed using bioNJ* [36,37] implemented in APE [38],
with K80 as molecular distance. Divergence is defined as the average Hamming distance per base
among these sequences.
Given the frequencies fi,x for the ith nucleotide (i = A,C,G,T) at position x in the window (ignoring
variants below the frequency threshold), and the length L of the window (including only sites with
depth above the threshold), the definitions of the statistics for genetic variability presented here are:




i fi,x < 1]/L (where ind[y] is 1 if y is true and 0 otherwise)













i fi,x log( fi,x)/L
• Tajima’s D: D = π−S/(0.5−log( fmin))S
Note that for Tajima’s D we use a simplified normalisation by SNP density, which differs from the
one usually used in population genetics; the latter is not useful here since the evolutionary model does
not correspond to a constant population size in time [39]. Note also that the normalization of the SNP
density within Tajima’s D calculation also considers a lower threshold fmin on variant frequencies.
3. Results
3.1. Samples and Read Depth
We analysed short-read data from CEF cells infected in vitro by the non-pathogenetic NDV strain
LaSota and the highly pathogenic Herts/33 [25], as well as from different tissues such as trachea [28],
lung [27], and spleen [26] harvested from in vivo experiments on Leghorn and Fayoumi chickens
infected with LaSota. Only a few in vivo samples—three from tracheas of susceptible Leghorn
chickens, two from tracheas of resistant Fayoumi ones—contained enough viral reads to characterise
genome-wide diversity (Table 1).
Notice that in vitro and in vivo samples are from very different experimental settings, hence the
timescales of the infection (12 h infection in culture vs. 2 days post-inoculation in chickens) are difficult
to compare. Unsurprisingly, samples from infections in vivo show a much greater heterogeneity in the
number of reads (Supplementary Table S1).
The coverage across the genome (Supplementary Figures S2–S3) depends on gene expression,
the proportion of mRNA and genomic RNA, and in minor measure from the specific sequence.
Intergenic regions and the region coding for the large RNA-dependent RNA polymerase (L) gene
usually have low coverage, especially if the fraction of genomic RNA is small. Note that the proportion
of mRNA and genomic RNA is likely to vary between genes, with mRNA dominating in highly
expressed genes. Throughout this work, we make the reasonable assumption that the genetic variability
in reads from mRNA reflects the genetic variability among genomic sequences in the viral population.
The large differences in read depth among genes and samples represent major issues since many
estimators of genetic diversity cannot be meaningfully compared with unequal read depth [32] or
should be properly normalised if a neutral evolutionary model can be assumed [33,34]; the same is true
for other statistics based on the frequency spectrum [35,40]. Moreover, there is a potential contribution
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of sequencing errors and other artefacts in sample preparation and sequencing [31] that could be
confounded with low-frequency variants and distort these statistics.
To avoid both these issues, we first removed all variants in regions of low read depth <100 reads
from the analysis, then ignored all remaining variants with frequency <0.02. This last threshold was
chosen such that any variant in the final set would be supported by at least two reads, reducing further
the risk of including sequencing errors. This approach implies that we do not explore the diversity of
very low frequency variants in the swarm, nor the diversity of the L gene in vivo, because its coverage
is too low.
3.2. Overall Genetic Diversity Show Higher Diversity in the In Vivo Samples
We measured the overall diversity in each of the in vivo and in vitro samples by three different
statistics [36]: the number of SNPs, the nucleotide diversity and the entropy statistics, all of them
computed per sample (Figure 1). A higher density of SNPs is observed for in vivo samples, while in vitro
samples are less diverse by an order of magnitude. As indicated above, the different experimental
conditions of the analyzed samples could explain the large difference in the number of accumulated
polymorphisms. The initial diversity of the inoculum could also matter, although it is unlikely to be the
reason for this difference given the high number of low frequency variants (which appeared recently,
see results in the next section).
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Figure 1. Genetic diversity of Newcastle disease virus (NDV) infection samples. The different diversity
meas s are plotted to log-scale (from left to right: single nucleotide polymorphism (SNP) density,
nucleotide diver ity and entropy). Sample_1 o each infection condition is black, sample_2 is blue and
sample_3 is red.
Although the variance within the samples from the same in vivo strains is relatively large,
all samples have the same pattern of diversity. Instead, for in vitro c nditions, viral popul tions
from different replicates have low variance, and the levels of diversity are quite low with respect
to in vivo condition (Figure 1). The other two statistics (pairwise nucleotide diversity and entropy,
Figure 1) are also correlated t the number of SNPs and follow similar patterns. Pairwise nucleotide
diversity is more sensitiv to higher frequencies while the number of SNPs is v ry sensitiv to rare
variants. The lower values observed at nucleotide diversity indicate a high fraction of vari nts at low
frequency. Entropy is also more sensitiv to lower frequencies than nucleotide diversity nd points t
the sam conclusi n.
3.3. An Excess of Low-Frequency Variants is Compatible with an Exponential Growth Rate within Host/Culture
The difference in patterns between SNP density and the nucleotide diversity provides information
about underlying evolutionary processes. If SNP density is high but diversity is low, it indicates that
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only low-frequency variants appear, which is suggestive of selective constraints. On the other hand,
regions with high diversity but low SNP density are suggestive of positive or diversifying selection.
Tajima’s D statistic shows the difference between estimates of genetic variability from pairwise
number of differences and SNP density. Negative values of Tajima’s D indicate that low-frequency
variants are more frequent than expected under a neutral model with a stationary population [34].
The estimates of the overall Tajima’s D for each of the samples are in all cases negative (Figure 2),
indicating an excess of low frequency variants in relation to intermediate frequency variants. An excess
of low-frequency variants may arise as a consequence of changes in population size, such as population
growth, but also of selective events, such as recent selective sweeps or purifying selection. The values are
not very different in vivo or in vitro (Figure 3), which suggest that both are caused by similar processes,
i.e., rapid population growth. Herts/33 infected samples having slightly higher values than LaSota
infected samples might be indicative of the selective pressure related to higher pathogenicity-triggered
host cell response.
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3.4. Genetic Diversity along the Genome Shows Regions of High Diversity and/or Hypermutability
The study of the diversity along the genome shows concordant patterns in relation to the overall
diversity (Figure 3, Supplementary Figure S4). Nevertheless, a number of interesting patterns arise.
Peaks of higher diversity are generally located at intragenic regions. Coding positions with lower
diversity are either the regions with stronger functional constraints or low mutation rates, while high
diversity regions may indicate hypermutability, relaxed functional constraints or diversifying selection.
There is no information about the L region except for a single replicate of Leghorn (Supplementary
Figure S5). Although noisy, this replicate shows a single high peak of diversity at intermediate
frequencies (high Tajima’s D values) that may involve a diversifying selective process. Nevertheless,
more valid replicates should be made to validate this pattern.
In vitro samples (right columns in Figure 3 and Supplementary Figure S4) show variants clearly
concentrated in non-coding regions, especially flanking the NP gene and at the 5′ end of the genome.
A similar pattern is shown among in vivo samples, where there are several peaks of diversity around
non-coding regions. Intriguingly, we observed a peak in HN for both CEF LaSota and Herts/33
infections. In vivo samples show variable diversity within and between genes. The matrix protein (M)
coding gene has consistently low diversity in vivo and in vitro. There are several peaks of diversity
in vivo, e.g., in the nucleocapsid protein (NP), fusion protein (F) and haemagglutinin-neuraminidase
protein HN coding genes. The diversity in phosphoprotein P coding region is high in the first part of
the coding sequence, before the RNA editing site.
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Figure 3. SNP density and Tajima’s D along the NDV genome for samples from multiple NDV infections.
The gray shadings outline protein coding regions. NP: nucleocapsid protein, P: phosphoprotein,
M: matrix protein, F: fusion protein, HN: haemagglutinin-neuraminidase protein, L: RNA polymerase.
Sample_1 of each infection condition is black, sample_2 is blue and sample_3 is red. Positions with no
points mean that these positions have no SNPs.
If population growth would be the only (demographic) process affecting the samples, Tajima’s D
would be approximately constant along the genome. Intra-host purifying selection would be reflected
in lower values of both diversity and Tajima’s D statistics, while positive/diversifying selection would
lead to higher values of both. The profile of Tajima’s D along the genome (Figure 3) suggests that
intra-host positive or diversifying selection could be acting on NP and HN, and purifying selection on
M. The pattern observed across the sequence indicates that Tajima’s D is variable across the sequence.
These peaks are generally shared among samples of the same strain. Negative peaks of Tajima’s D
(excess of low frequency variants) are indicating stronger constraints to increase the variant frequency,
e.g., for the M gene. Nevertheless, for other genes, they are not shared with the reduction in SNP
diversity across sequences.
3.5. The Site Frequency Spectrum (SFS) Gives Clues about Evolutionary Events Occurring within Host
A more complete picture is provided by the site frequency spectrum (Figure 4), i.e., the distribution
of minor allele frequencies at polymorphic sites [34]. We observe that the Leghorn strain is quite
different in relation to others: Two of the samples have a long tail of higher frequency variants
(especially the sample 2, which has a Tajima’s D value close to zero and high diversity). The pattern
confirms that, generally, the mutations are at low frequency and are not increasing in frequency. In most
samples (except Leghorn sample 2 and Herts/33) there is a lack of intermediate frequency mutations,
even assuming exponential population growth (Supplementary Figure S6), which is possibly due to
initial super-exponential expansion or negative selection. At least sample 2 in Leghorn exhibits a
power-law regime with exponent –2 at low frequencies and a drop at higher frequencies, which suggest
Viruses 2020, 12, 1305 9 of 19
exponential expansion and either a short initial phase of super-exponential expansion or relaxed
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Figure 4. Plot of the site frequency spectrum of variants for samples from multiple NDV infections.
In vivo samples are shown at the left column, while in vitro samples are shown at right. X-axis indicate
the frequency of the variant and y-axis indicates the number of variants for each interval. Each replicate
sample is shown with different colors, as indicated in legend.
3.6. Looking for Signatures of Selection: Non-Synonymous, Synonymous and Non-Coding Variants
The effect of natural selection can be detected by comparing the diversity patterns of non-functional
positions (assumed to be approximately neutral, such as some intergenic and synonymous positions)
with functional positions (which are affected by selective processes, beneficial or deleterious). In the
case that functional positions have lower levels of diversity than non-functional, it is suggestive of the
presence of negative selection that is eliminating new non-beneficial variants, while higher levels of
diversity may indicate diversifying selection. The effect of selective process can be evaluated across
time by comparing the levels of (intra-host) polymorphism and (between-host) divergence. If the
ratios of polymorphism and divergence are dissimilar, it is indicative of differential selective effects.
This kind of analysis is useful for comparing the selective effects within-host (here, polymorphism)
in relation to between-host (here, divergence).
We have used as a proxy of functional positions the first and second codon positions, as they are
mainly non-synonymous positions, while third codon positions are considered here as non-functional
at the protein level, as they are mainly synonymous. Note that we consider only the main reading
frame for the P-coding region, neglecting the frames coding for the V and W proteins downstream the
site of RNA editing. We additionally compared the third codon position with non-coding positions,
since both are approximately non-functional at the amino acid level, although they are possibly under
different selective pressures at the RNA level.
3.6.1. Ratios of Polymorphism within-Host at Functional Versus Non-Functional Positions
Figure 5A shows the ratio of 1st plus 2nd versus 3rd positions at all coding regions. We observe
that the in vivo strains have moderate selective constraints at 1st and 2nd positions (around 0.6–0.8
with respect to the 3rd position). Nevertheless, the in vitro strains present a very variable pattern:
the attenuated strain (LaSota) is highly variable and presents weak constraints (close to 1), while the
virulent strain (Herts/33) shows the highest suppression of non-synonymous diversity at functional
regions (around 0.2).
Figure 5B shows that the 3rd codon position is not neutral, as we observe in all strains and most
(except one) of samples moderate to high suppression of variability at the 3rd codon position versus
non-coding. The observed pattern is surprisingly similar to Figure 5A but shows stronger constraints
on the 3rd codon positions at both in vitro samples. That suggest that the selection on 1st plus 2nd
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positions versus non-coding is very strong in the in vitro infections, but moderately strong in the
in vivo ones.
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If we look in more detail at individual variants along the whole sequence, the distribution of
the first, second, third and non-coding positions from the in vivo samples (Supplementary Figure S7)
shows that variants are widely distributed across all expressed segments, with high diversity at coding
and non-coding variants but remaining at low frequency. Only one in vivo sample contained enough
reads from the L coding region and contained a number of variants located there. Instead, the in vitro
samples show very different patterns, with mostly variants at non-coding and third codon positions,
distributed across all frequencies, although predominantly at lower frequencies. Non-coding variants
appear to be strongly localized, possibly suggesting hypermutability. In contrast to the LaSota strain,
Herts/33 reads contain almost no functional variants but only non-coding or third variant positions.
3.6.2. The Patter s of Polymorphism within-Host Versus the Divergence between-Host Are not
Always Correlated
Under a neutral model, it is expected that new variants appear at the same pace along the
time. Thus, the number of variants observed within-host should be correlated with the variants
observed b tween-host. Changes in the expected pattern in some regions usually indicate differen al
selective pressures within- d between-hosts. This comparison is the basis for analyses such as HKA
(Hudson–Kreitman and Aguadé test) [41].
Figures 6 and 7 show the l vels f nucleotide dive sity within host/culture and within-genotype
divergence fo in vitro and in vivo samples, respectively. In respect of in vitro samples, the low levels
of nucleotide diversity within-host preclude an exhaustive comparison, a the va iance seems too large
(that is, a single variant can give a high eak in a given region), but we see hat regions with higher
divergence between-host tend to exhibit peaks within host. Surprisingly, the F and HN regions show
different peak at betw en-host level for the differ nt genotyp s.
Instead, for in vivo samples, h number of vari nts is gh enough to observe clear trends across
the sequenc s. The main differences from a correlated within-host polymorphism versus between-host
diverge ce pattern are summariz d in Table 2. Specific lly, the patt rns at between-host show a general
suppression of diversity within coding regions and higher at intergenic sequences (IGS), with th
exception of the HN coding region that exhibits two high peaks of variability. This between- st
Viruses 2020, 12, 1305 11 of 19
pattern of diversity, in contrast to within-host diversity, may determine regions susceptible to the
selection pressures during transmission. We observe (i) a higher diversity at within-host level than
expected under the normalised pattern at the central part of NP coding region, (ii) a lower diversity at
M coding region, (iii) a higher diversity at the F coding region within-host in relation to between-host
and (iv) a very low diversity within-host at the HN coding region. We also see a high peak of diversity
for the single Leghorn replicate at the L region (between 11,200–11,400 bp) (Supplementary Figure S8),
which may be explained by diversifying selection.















































Figure 6. Within-host polymorphisms (in color) and between-host (black) divergence per position for
in vitro samples. Above plot shows the pattern of LaSota (genotype II) samples while below is shown
the Herts/33 (genotype IV) samples. NP: nucleocapsid protein, P: phosphoprotein, M: matrix protein,
F: fusion protein, HN: haemagglutinin-neuraminidase protein, L: RNA polymerase.
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Figure 7. Normalised genetic diversity ( l ll enotype I in vivo samples: blue/green
lines, divergence bet ee I sequences: black line) versus genomic p sition, excluding
the L protein. Here, the normalis d genetic diversity is the running average of genetic diver ity
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(sample_1 to sample_2, dark to light).
Viruses 2020, 12, 1305 12 of 19
Table 2. Main differences in within- versus between-host variability patterns.



















(3290–4384) 5018–5019 6589–6593 7219–7220
3.6.3. Contrasting the Patterns of Polymorphism within-Host Versus the Divergence between-Host at
Functional Versus Non-Functional Positions: Differential Selective Patterns at Different Stages
As indicated above, the ratio of both divergence and diversity at functional (non-synonymous) versus
non-functional (synonymous) positions can detect differential selective effects acting on these positions.
Assuming that the 3rd codon position is neutral, a value of this ratio below the unity indicates a selective
constraint at functional positions between hosts or relaxed constraints/positive selection within host, while
a value higher than one indicates an excess of substitutions at functional positions, corresponding to
evolutionary constraints within-host or positive selection between hosts. The comparison between these
ratios for polymorphisms and divergence is the basis for the celebrated McDonald–Kreitman test [41].
Selective constraints in functional regions are expected because selection purge most of variants
affecting protein function and stability. Figure 8 shows the plot along the sequence of the ratios
at functional versus non-functional positions for both polymorphisms and divergence. Table 3 and
Supplementary Table S2 show the patterns of the ratios separated by coding regions and the values
of the levels and ratios per region. We observe very high ratios above one in within-host samples,
specifically at P, M and HN coding regions. Instead, the between-host ratios remain clearly below one.
Even accounting for this different baseline, we observe some very striking signals of differences in
within-host/between-host selection: strong positive within-host selection in the middle of the P gene,
but negative within-host selection before position 4000 in the genome, in the first half of the M gene,
then positive again in the middle of HN. For the L region (Supplementary Figure S9), the highest peak
(between 11,500–11,950 bp) of nonsynonymous diversity is observed at the single Leghorn replicate,
compatible with a diversifying selection process at that specific region.






















Figure 8. (1st–2nd base)/3rd base in codon within-host polymorphism (green and blue colors
for each strain) and divergence between-host (black color) vs. position. Running avg. across 250
amino acids. NP: nucleocapsid protein, P: phosphoprotein, M: matrix protein, F: fusion protein,
HN: haemagglutinin-neuraminidase protein. Blue lines are Leghorn samples (sample_1 to sample_3,
dark to light), green lines are Fayoumi samples (sample_1 to sample_2, dark to light).
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Table 3. Regions with candidate patterns for intra-host positive selection obtained by comparison of
ratios of polymorphisms in functional versus non-functional positions versus ratios in divergence.
Protein NP P M F F HN HN




600–900 2300–2700 3550–3800 4750–4850 5200–5350 6600–6750 7100–7400
4. Discussion
In this work, we presented the first complete and exhaustive analysis of genetic diversity in
NDV quasispecies. This study leveraged deep sequencing of NDV-infected chicken cells from in vitro
and in vivo experiments to understand patterns of genetic diversity within-host and compare them
between strains and chicken breeds. As expected for RNA viruses, our results revealed a rich
pattern of diversity and selection in the viral swarms, especially in vivo. It is important to remember
that the experiments in vivo and in vitro have been performed with different conditions and they
cannot be directly compared. In fact, the in vivo and in vitro experiments have been performed
with different inoculation quantity and at different replication times. On the other hand, contrasting
differences or similarities may provide information on common evolutionary processes occurring
during these infections.
LaSota-infected in vivo Leghorn and Fayomi chicken lines showed higher overall genetic diversity
by all measures (SNP density, nucleotide diversity, and entropy) and more heterogeneous levels of
genetic diversity compared to the in vitro LaSota/Herts/33-infected CEF cells. More genetic diversity
in in vivo samples could be explained by natural host habitat, effective virus replication, heterogenous
microenvironment within host, and selective pressure from the host immune system. Schilling et al.
have demonstrated strong innate immune response in chicken embryos at various stages of development
upon infection with LaSota [42]; whereas in vitro samples are likely to have more homogeneity in the
microenvironment posing less selection pressure. NDV completes a single round of multiplication
cycle in 10 to 12 h. The observed higher genetic diversity in the in vivo samples (RNA harvested after
2 dpi) had up to four rounds of multiplication cycles compared to the one round of multiplication cycle
of in vitro samples (RNA harvested after 12 hpi). More rounds of replication in the in vivo samples
provide more opportunities to generate genetic diversity.
All frequency spectra were broadly consistent with a fast-exponential expansion of the viral
population, but some of them showed a further deficit of intermediate frequency variants beyond the
expectations from exponential growth. This could be attributed either to an early super-exponential
phase in the infection, or to negative selection on the variants [34]. The latter is a likely explanation,
given the widespread signatures of negative selection found both at the RNA and protein level.
Our most interesting findings involve the patterns of diversity and selection across the NDV
genome. For example, variants from culture samples were mostly concentrated in non-coding regions
of NDV genes. These regions include two cis-acting extragenomic regulatory elements, flanking the
six NDV genes: 3′ leader and 5′ trailer sequences, which participate in viral replication, transcription,
and genomic/antigenomic RNA packaging. Variants in cultured viruses were concentrated in these
two regions, especially the 3′ leader (LaSota) and the 5′ trailer (Herts/33). Each NDV gene is flanked by
3′ and 5′ untranslated regions (UTR), which are followed by conserved transcription control sequences
at the beginning and the end of the gene known as GS and GE elements, respectively, and in between
two genes there are non-coding intergenic sequences (IGS). The non-coding IGS elements are conserved
in NDV strains but vary in length amongst NDV strains [8–10,43]. Yan et al. [44] conducted a study
on modification of IGS regions between the fusion protein (F) and haemagglutinin-neuraminidase
protein (HN) coding genes and between HN and RNA-dependent RNA polymerase (L) coding genes
and showed that NDV can tolerate changes in IGS up to 365 nucleotides. However, their study also
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confirmed that protracted IGS downregulated the transcription of downstream genes such as F and
HN and proposed that 31 and 47 nucleotides long IGS in F-HN and HN-L respectively are required
for effective transcription of downstream genes. Their study also showed that modification of IGS
in terms of either increase or decrease in length resulted in the attenuation of the virus in 1-day-old
and 6-week-old chickens [44]. The evolutionary flexibility and the relaxed constraints in these regions,
compared to coding sequences, is the likely cause of the excess of variants in intergenic regions.
The levels of genetic diversity in CEF cells infected with genotype II strain LaSota (avirulent) and
genotype IV strain Herts/33 (highly pathogenic) were similar, but we found striking differences in
their genomic patterns. The clear deficit of variants within coding regions suggests that Herts/33 is
under more intense purifying selection on coding sequences compared to LaSota, both in culture and
between hosts.
The analysis of in vivo samples provided a rich picture of selection within and between hosts for
NDV genes, although this picture is restricted to genotype II (LaSota).
The NDV nucleocapsid protein (NP) is encoded by the NP gene present at the 3′ end of the
genome and it is the first gene to be transcribed. NP is an RNA binding protein which coats genomic
and antigenomic viral RNA to form biologically active templates and also protect it from nucleases.
NP interacts with phosphoprotein (P) and large RNA polymerase (L) proteins to form the RNP complex
necessary for transcription and replication. NDV and other paramyxoviruses such as PIV5 and HPIV3
follow ‘the rule of six’, where viral genome is a multiple of hexameric nucleotides in length as NP
protein monomer forms a nucleocapsid helical structure spanning six nucleotides and ensures efficient
transcription and replication in natural infections [45]. A protective conserved B-cell immunodominant
epitope has been identified in NDV NP spanning 444 to 459 amino acid residues responsible for evoking
antibody response in infected chickens which is proving important for vaccine development [46].
In our study, we found a curious combination of intra-host positive or diversifying selection at
the RNA level on the coding region of the NP gene, and purifying selection pressure on the amino acid
sequence. In fact, Fan et al. examined molecular evolution of NP protein amongst NDV genotypes and
suggested that NP could have been under purifying selection as abundance of negatively selected sites
and low dN/dS indicated for NP. In this study it is shown that NP has greater genetic diversity, but NP
structure and function is well conserved [47]. This observation is explained well by our findings.
The phosphoprotein (P) protein is an important component of the RNP complex by interacting
with NP and L proteins necessary for viral RNA synthesis. NDV expresses two non-structural accessory
proteins V and W by co-transcriptional modification of P mRNA at the conserved hexameric site
3′-UUUUUCC-5′ by adding non-template guanine residues G, viz. +G (V) and +GG (W). P/V/W
proteins share amino terminal but have different carboxyl terminals [48]. In the NDV-infected chicken
cells, insertion of more than two guanine residues leading to a supplementary amino acid residue is a
rare but possible occurrence [49]. The coexistence of three different coding frames for a part of the P
coding sequence obfuscates the interpretation of dN/dS analyses.
The NDV V protein is known to have multiple functions: it antagonises type I interferons
mediated MDA5 binding [50], V protein inhibits apoptotic cell death in infected host cells to promote
virus replication [51,52], and also plays an important role in virus tropism and pathogenicity [53,54];
by contrast, very little is known about W protein. In our study, we have observed signatures compatible
with stronger negative within-host selection on V and W protein sequences compared to the P protein.
Rao et al. confirmed that negative selection pressure on V and W (dN/dS < 1) in different avian
paramyxoviruses indicate conservation of non-structural NDV proteins to be essential for virus
functions [55].
The matrix (M) protein is located beneath the viral envelope and has a crucial role in virion
assembly mediated through interaction with NP, cytoplasmic region of HN protein, and host cell
lipid membrane. M protein is also required for transport of viral components at the site of assembly
and deformation of host cell membrane for the budding process [56] and M is also critical for the
formation of virus-like particles [57]. A majority of synonymous nucleotide substitutions has been
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demonstrated in various NDV field isolates by phylogenetic analysis with fewer non-synonymous
nucleotide substitutions, supporting the hypothesis that the conservation of M protein is necessary
for survival of the virus [58]. In this study we observed that the selective constraints and the low
diversity of the M sequence have their origin within hosts. Intra-host competition and very strong
fitness constraints on the amino acid sequences reduce the diversity in the coding region of the M gene,
confirming the importance of the conserved M gene to maintain optimal growth of viral populations.
The fusion (F) protein is a transmembrane glycoprotein embedded in the viral envelope responsible
for viral entry and egress by tethering to HN protein. The number of basic amino acids in fusion
protein cleavage site (FPCS) is one of the main determinants of pathogenicity [9,59]. The inactive
precursor of F0 is essential to be cleaved by proteases to form biological active F2 (1–117 aa) and F1
(118–553 aa) subunits. The FPCS fall between 112-G/E-K/R-Q-G/E-R↓L-117 (4894 to 4912 nucleotide
positions of the NDV genome), after cleavage F1 and F2 subunits are covalently linked by disulphide
bonds. Biologically active F protein has signal sequence (F2), transmembrane domain (F1), cleavage
site, hydrophobic peptide, the heptad repeats [HRA(F1), HRB (F1), and HRC(F2)], and cytoplasmic
tail (F1). The transmembrane domain is essential for interaction with HN and fusion activity whereas
heptad repeats are essential for protein–protein interaction. HRB upstream to the transmembrane
domain has a highly conserved leucine zipper motif; however, the role of heptad HRA and HRC
closest to the cleavage site are yet to be determined [60]. NDV F protein is also known to have three
antigenic determinants at amino acid positions 343, 72, and 161 which have shown capacity of high
fusion-inhibition and neutralization [61]. The antigenic determinants 72 and 161 are in closest proximity
to HRC (F2) and HRA(F1) at the end of FPCS. In this study we have observed negative selection pressure
on the region containing the FPCS between hosts, and signatures of intra-host purifying selection at the
amino acid level, indicating evolutionary constraints on FPCS both within and especially between hosts.
On the other hand, a clear signature of positive selection on the protein sequence is observed in the
regions containing the first antigenic determinant near HRC (F2), suggesting diversification of antigenic
determinants in response to host cell immunity, and a second clear signature of positive/diversifying
selection between amino acid positions 215–265 of middle portion of the F1 subunit.
The haemagglutinin-neuraminidase (HN) is a very important membrane glycoprotein responsible
for the attachment of virus to host cell sialic acid conjugated receptors and interaction with the F
protein facilitating virus entry. HN also has neuraminidase activity, which cleaves sialic acid and helps
in releasing the progeny virus as well as prevention of self-association. The length of HN protein
varies up to seven lengths in NDV strains, the majority of NDV strains comprises a 571 amino acid
long HN protein [62]. NDV HN protein structure contains carboxy terminal globular head and stalk
domain at amino terminal. The receptor binding, neuraminidase activity, and antigenic determinants
are located in the globular head of HN protein. One of the two main signatures of positive selection
at the protein level is located also in the globular head (aa 220–330), while the other (aa 60–120) is
located in the stalk domain, which contains F protein interaction site and fusion promotion activity.
The glycosylation sites required for HN protein binding with host cell receptors are conserved in NDV
strains and believed to be essential for virus infection and replication [63,64]. The cytoplasmic tail
at amino terminal is highly conserved in HN to ensure the interaction with M protein essential for
viral assembly [65]. HN protein is also a determinant of NDV tropism and virulence in a variety of
cells [66,67]. The abundance of antigenic determinants makes HN a natural target of positive selection
to escape the immune pressure. However, the regions we identified under positive selection within
and between hosts do not correspond to known epitopes. Neutralisation assays of neuraminidase and
haemagglutination activity using monoclonal antibodies confirmed the antigenic epitopes in various
sites comprising amino acid residues 171 to 205, 193 to 201, 345 to 353 and residues 513 to 521 in
addition with 494 and 569 [68].
Finally, for the large RNA-dependent RNA polymerase (L) gene, we do not have enough
information for the in vivo experiments. Only one replicate from Leghorn chicken had enough read
depth to be considered for analysis. Therefore, more valid replicates should be obtained for having more
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robust conclusions. Nevertheless, the obtained information point to strong diversifying selection at a
specific region located around position 11,500–11,950 bp but purifying selection at between-host level.
As final conclusions, the analysis of diversity performed on NDV has detected signals of positive
selection within-host, which are different from between host, implicating different forces acting in
different regions at different stages of the life cycle of the virus. This is an interesting finding that can
help to understand the evolution of these organisms. Furthermore, we allocate a number of functional
regions affected by positive selection on their possible role in the evolution of the infection.
We are still a long way from a complete description of the patterns of genetic diversity in RNA
and DNA viruses with high mutation rates, and even farther away from an understanding of the
functional consequences of this diversity for quasispecies dynamics [1–3]. However, the unprecedented
availability of deep sequencing datasets like the ones analysed here enables detailed inference of
selective pressures within and between hosts and provides a promising basis for future investigations.
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sequences: black line) versus genomic position. and Figure S9: (1st–2nd base)/3rd base in codon within-host
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